Market Cap (In TWD)
3.77 Billion
Revenue (In TWD)
20.63 Million
Net Income (In TWD)
-57.95 Million
Avg. Volume
291.75 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 18.8-51.0
- PE
- -
- EPS
- -
- Beta Value
- 0.427
- ISIN
- TW0006808009
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- -
- Employee Count
- -
- Website
- https://www.3dglobalbiotech.com.tw
- Ipo Date
- 2020-12-25
- Details
- 3D Global Biotech Inc. develops medical materials for human body reconstruction in China. It uses cell culture systems, 3D printing technology, and bio-inks hydrogel as the basis to develop and produce customized autologous cell-based medical products. The company develops human tissue and organ reconstruction platforms; develops customized and personalized medical equipment; and conducts professional research. It offers artificial bone substitute, skull fixation system, biological dressings, bio inks, and bioprinting equipment, as well as orthopedic, tooth and jaw, and skull reconstruction products, and scalp care products. It serves medical centers, research institutions, and companies and distributors to establish an interdisciplinary alliance encompassing industry, government, academia, research, and medicine. The company was founded in 2014 and is based in New Taipei City, China.
More Stocks
-
9KF
-
AMBI
-
KKOYYKesko Oyj
KKOYY
-
AZL
-
EQV1VeQ Oyj
EQV1V
-
TDC
-
1090
-
BAROEXTBaroda Extrusion Limited
BAROEXT